Passage BIO, Inc. — Director's Dealing 2024

Aug 9, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Passage BIO, Inc. (PASG)
CIK: 0001787297
Period of Report: 2024-08-07

Reporting Person: Lynx1 Capital Management LP (10% Owner)
Reporting Person: Nichols Weston (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, $0.0001 par value per share	8426955	Indirect

Footnotes

F1: The securities to which this filing relates are held directly by Lynx1 Master Fund LP to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any.